Pure Global

"Leica" Bond Ready-to-Use Primary Antibody Cytokeratin 5 (XM26)(Non-Sterile) - Taiwan Registration d10a0760495768352d6a8db22da948e8

Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody Cytokeratin 5 (XM26)(Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d10a0760495768352d6a8db22da948e8 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
d10a0760495768352d6a8db22da948e8
Registration Details
Taiwan FDA Registration: d10a0760495768352d6a8db22da948e8
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Leica" Bond Ready-to-Use Primary Antibody Cytokeratin 5 (XM26)(Non-Sterile)
TW: โ€œ้Œธๅกโ€้‚ฆๅพทๅณ็”จๅž‹็ดฐ่ƒž่ง’่ณช่›‹็™ฝ5ไธ€็ดšๆŠ—้ซ”(ๆœชๆป…่Œ)
Risk Class 1
MD

Registration Details

d10a0760495768352d6a8db22da948e8

Ministry of Health Medical Device Import No. 019851

DHA09401985108

Company Information

Product Details

Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.

B Hematology and pathology devices

B1860 Immunopathological histochemical reagents and kits

Imported from abroad

Dates and Status

Nov 26, 2018

Nov 26, 2028